Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 801896, 28 pages
http://dx.doi.org/10.1155/2014/801896
Review Article

Endothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention

1Section of Anatomy and Physiopathology, Department of Clinical and Experimental Sciences, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
2Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Viale Europa 11, 25123 Brescia, Italy

Received 15 November 2013; Accepted 11 January 2014; Published 26 February 2014

Academic Editor: Iveta Bernatova

Copyright © 2014 Gaia Favero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Gori, S. Dragoni, G. di Stolfo, and S. Forconi, “Endothelium and haemorheology,” Annali dell'Istituto Superiore di Sanita, vol. 43, no. 2, pp. 124–129, 2007. View at Google Scholar · View at Scopus
  2. T. Minami and W. C. Aird, “Endothelial cell gene regulation,” Trends in Cardiovascular Medicine, vol. 15, no. 5, pp. 174–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. W. C. Aird, “Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. R. Weibel and G. E. Palade, “New cytoplasmic components in arterial endothelia,” The Journal of Cell Biology, vol. 23, pp. 101–112, 1964. View at Google Scholar · View at Scopus
  5. W. C. Aird, “Phenotypic heterogeneity of the endothelium: II. Representative vascular beds,” Circulation Research, vol. 100, no. 2, pp. 174–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Yano, D. Gale, S. Massberg et al., “Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium,” Blood, vol. 109, no. 2, pp. 613–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. C. Aird, “Endothelium in health and disease,” Pharmacological Reports, vol. 60, no. 1, pp. 139–143, 2008. View at Google Scholar · View at Scopus
  8. H. F. Galley and N. R. Webster, “Physiology of the endothelium,” British Journal of Anaesthesia, vol. 93, no. 1, pp. 105–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. H. G. Augustin, D. H. Kozian, and R. C. Johnson, “Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes,” BioEssays, vol. 16, no. 12, pp. 901–906, 1994. View at Google Scholar · View at Scopus
  10. D. B. Cines, E. S. Pollak, C. A. Buck et al., “Endothelial cells in physiology and in the pathophysiology of vascular disorders,” Blood, vol. 91, no. 10, pp. 3527–3561, 1998. View at Google Scholar · View at Scopus
  11. J.-P. Girard and T. A. Springer, “High Endothelial Venules (HEVs): specialized endothelium for lymphocyte migration,” Immunology Today, vol. 16, no. 9, pp. 449–457, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Miyasaka and T. Tanaka, “Lymphocyte trafficking across high endothelial venules: dogmas and enigmas,” Nature Reviews Immunology, vol. 4, no. 5, pp. 360–370, 2004. View at Google Scholar · View at Scopus
  13. F. Florey, “The endothelial cell,” British Medical Journal, vol. 2, no. 5512, pp. 487–490, 1966. View at Google Scholar · View at Scopus
  14. E. Wisse, “An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids,” Journal of Ultrasructure Research, vol. 31, no. 1-2, pp. 125–150, 1970. View at Google Scholar · View at Scopus
  15. M. Simionescu, N. Simionescu, and G. E. Palade, “Morphometric data on the endothelium of blood capillaries,” The Journal of Cell Biology, vol. 60, no. 1, pp. 128–152, 1974. View at Google Scholar · View at Scopus
  16. A. Caggiati, M. Phillips, A. Lametschwandtner, and C. Allegra, “Valves in small veins and venules,” European Journal of Vascular and Endovascular Surgery, vol. 32, no. 4, pp. 447–452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Feng, J. A. Nagy, H. F. Dvorak, and A. M. Dvorak, “Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals,” Microscopy Research and Technique, vol. 57, no. 5, pp. 289–326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Frenette, R. C. Johnson, R. O. Hynes, and D. D. Wagner, “Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7450–7454, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Mori, J. W. Salter, T. Vowinkel, C. F. Krieglstein, K. Y. Stokes, and D. N. Granger, “Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules,” American Journal of Physiology, vol. 288, no. 5, pp. G920–G926, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Tailor and D. N. Granger, “Hypercholesterolemia promotes leukocyte-dependent platelet adhesion in murine postcapillary venules,” Microcirculation, vol. 11, no. 7, pp. 597–603, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Cooper, J. Russell, K. D. Chitman, M. C. Williams, R. E. Wolf, and D. N. Granger, “Leukocyte dependence of platelet adhesion in postcapillary venules,” American Journal of Physiology, vol. 286, no. 5, pp. H1895–H1900, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Kraal and R. E. Mebius, “High endothelial venules: lymphocyte traffic control and controlled traffic,” Advances in Immunology, vol. 65, pp. 347–395, 1997. View at Google Scholar · View at Scopus
  23. U. H. von Andrian and T. R. Mempel, “Homing and cellular traffic in lymph nodes,” Nature Reviews Immunology, vol. 3, no. 11, pp. 867–878, 2003. View at Google Scholar · View at Scopus
  24. P. R. Streeter, B. T. Rouse, and E. C. Butcher, “Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes,” The Journal of Cell Biology, vol. 107, no. 5, pp. 1853–1862, 1988. View at Google Scholar · View at Scopus
  25. A. O. Anderson and S. Shaw, “T cell adhesion to endothelium: the FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node,” Seminars in Immunology, vol. 5, no. 4, pp. 271–282, 1993. View at Google Scholar · View at Scopus
  26. D. L. Brutsaert, “Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity,” Physiological Reviews, vol. 83, no. 1, pp. 59–115, 2003. View at Google Scholar · View at Scopus
  27. D. A. Narmoneva, R. Vukmirovic, M. E. Davis, R. D. Kamm, and R. T. Lee, “Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration,” Circulation, vol. 110, no. 8, pp. 962–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Yamamoto, V. de Waard, C. Fearns, and D. J. Loskutoff, “Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo,” Blood, vol. 92, no. 8, pp. 2791–2801, 1998. View at Google Scholar · View at Scopus
  29. H. Cai, Z. Li, A. Goette et al., “Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke,” Circulation, vol. 106, no. 22, pp. 2854–2858, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. L. J. Andries, D. L. Brutsaert, and S. U. Sys, “Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium,” Circulation Research, vol. 82, no. 2, pp. 195–203, 1998. View at Google Scholar · View at Scopus
  31. J. Bischoff and E. Aikawa, “Progenitor cells confer plasticity to cardiac valve endothelium,” Journal of Cardiovascular Translational Research, vol. 4, no. 6, pp. 710–719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. R. J. Esper, R. A. Nordaby, J. O. Vilariño, A. Paragano, J. L. Cacharrón, and R. A. Machado, “Endothelial dysfunction: a comprehensive appraisal,” Cardiovascular Diabetology, vol. 5, article 4, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Dejana, M. Corada, and M. G. Lampugnani, “Endothelial cell-to-cell junctions,” FASEB Journal, vol. 9, no. 10, pp. 910–918, 1995. View at Google Scholar · View at Scopus
  34. K. A. Pasyk and B. A. Jakobczak, “Vascular endothelium: recent advances,” European Journal of Dermatology, vol. 14, no. 4, pp. 209–213, 2004. View at Google Scholar · View at Scopus
  35. A. G. Passerini, D. C. Polacek, C. Shi et al., “Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2482–2487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Lupu, A. D. Westmuckett, G. Peer et al., “Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis,” American Journal of Pathology, vol. 167, no. 4, pp. 1161–1172, 2005. View at Google Scholar · View at Scopus
  37. M. P. Bevilacqua, J. S. Pober, D. L. Mendrick, R. S. Cotran, and M. A. Gimbrone Jr., “Identification of an inducible endothelial-leukocyte adhesion molecule,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9238–9242, 1987. View at Google Scholar · View at Scopus
  38. M. P. Bevilacqua, S. Stengelin, M. A. Gimbrone Jr., and B. Seed, “Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins,” Science, vol. 243, no. 4895, pp. 1160–1165, 1989. View at Google Scholar · View at Scopus
  39. M. Uematsu, Y. Ohara, J. P. Navas et al., “Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress,” American Journal of Physiology, vol. 269, no. 6, part 1, pp. C1371–C1378, 1995. View at Google Scholar · View at Scopus
  40. S. Verma, M. R. Buchanan, and T. J. Anderson, “Endothelial function testing as a biomarker of vascular disease,” Circulation, vol. 108, no. 17, pp. 2054–2059, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Yanagisawa, A. Inoue, T. Ishikawa et al., “Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 18, pp. 6964–6967, 1988. View at Google Scholar · View at Scopus
  42. J. W. Butany, S. Verma, R. L. Leask, B. Mohsen, and S. L. Asa, “Genetic abnormalities of the endothelium,” Microscopy Research and Technique, vol. 60, no. 1, pp. 30–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Thorin and D. J. Webb, “Endothelium-derived endothelin-1,” Pflugers Archiv, vol. 459, no. 6, pp. 951–958, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Rezzani, L. Rodella, and R. Bianchi, “Induction of endothelin in rat kidney after cyclosporine A treatment,” Acta Histochemica, vol. 103, no. 4, pp. 423–431, 2001. View at Google Scholar · View at Scopus
  45. R. Rezzani, L. Rodella, B. Buffoli et al., “Change in renal heme oxygenase expression in cyclosporine A-induced injury,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 1, pp. 105–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. L. F. Rodella, F. Filippini, F. Bonomini, R. Bresciani, R. J. Reiter, and R. Rezzani, “Beneficial effects of melatonin on nicotine-induced vasculopathy,” Journal of Pineal Research, vol. 48, no. 2, pp. 126–132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. L. F. Rodella, G. Favero, C. Rossini et al., “Aging and vascular dysfunction: beneficial melatonin effects,” Age, vol. 35, no. 1, pp. 103–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M.-E. Lee, K. D. Bloch, J. A. Clifford, and T. Quertermous, “Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence,” Journal of Biological Chemistry, vol. 265, no. 18, pp. 10446–10450, 1990. View at Google Scholar · View at Scopus
  49. G. P. Rossi, A. Sacchetto, M. Cesari, and A. C. Pessina, “Interactions between endothelin-1 and the renin-angiotensin-aldosterone system,” Cardiovascular Research, vol. 43, no. 2, pp. 300–307, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. G. P. Rossi, A. Sacchetto, D. Rizzoni et al., “Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 949–956, 2000. View at Google Scholar · View at Scopus
  51. A. W. Hahn, T. J. Resink, T. Scott-Burden, J. Powell, Y. Dohi, and F. R. Bühler, “Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function,” Cell Regulation, vol. 1, no. 9, pp. 649–659, 1990. View at Google Scholar · View at Scopus
  52. C.-P. Sung, A. J. Arleth, B. L. Storer, and E. H. Ohlstein, “Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle,” Journal of Pharmacology and Experimental Therapeutics, vol. 271, no. 1, pp. 429–437, 1994. View at Google Scholar · View at Scopus
  53. H. Ito, Y. Hirata, S. Adachi et al., “Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes,” Journal of Clinical Investigation, vol. 92, no. 1, pp. 398–403, 1993. View at Google Scholar · View at Scopus
  54. P. Moreau, H. Takase, C. F. Küng, S. Shaw, and T. F. Lüscher, “Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension,” Hypertension, vol. 29, no. 3, pp. 763–769, 1997. View at Google Scholar · View at Scopus
  55. R. P. McEver, J. H. Beckstead, K. L. Moore, L. Marshall-Carlson, and D. F. Bainton, “GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies,” Journal of Clinical Investigation, vol. 84, no. 1, pp. 92–99, 1989. View at Google Scholar · View at Scopus
  56. K. Iiyama, L. Hajra, M. Iiyama et al., “Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation,” Circulation Research, vol. 85, no. 2, pp. 199–207, 1999. View at Google Scholar · View at Scopus
  57. M. D. Chávez, N. Lakshmanan, and M. Kavdia, “Impact of superoxide dismutase on nitric oxide and peroxynitrite levels in the microcirculation—a computational model,” in Proceedings of the 29th Annual International Conference of IEEE Engineering in Medicine and Biology Society (EMBS '07), pp. 1022–1026, Lyon, France, August 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Sharma, P. N. Bernatchez, and J. B. de Haan, “Targeting endothelial dysfunction in vascular complications associated with diabetes,” International Journal of Vascular Medicine, vol. 2012, Article ID 750126, 12 pages, 2012. View at Publisher · View at Google Scholar
  59. C.-L. M. Cooke and S. T. Davidge, “Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice,” Cardiovascular Research, vol. 60, no. 3, pp. 635–642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Goto, T. Nishikawa, K. Sonoda et al., “Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice,” Biochemical and Biophysical Research Communications, vol. 366, no. 3, pp. 814–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Contrino, G. Hair, D. L. Kreutzer, and F. R. Rickles, “In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease,” Nature Medicine, vol. 2, no. 2, pp. 209–215, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Crawley, F. Lupu, A. D. Westmuckett, N. J. Severs, V. V. Kakkar, and C. Lupu, “Expression, localization, and activity of tissue factor pathway inhibitor in normal and athrosclerotic human vessels,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 5, pp. 1362–1373, 2000. View at Google Scholar · View at Scopus
  63. A. Solovey, R. Kollander, A. Shet et al., “Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin,” Blood, vol. 104, no. 3, pp. 840–846, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Nagayasu, S. Saadi, R. A. Holzknecht, T. B. Plummer, and J. L. Platt, “Expression of tissue factor mRNA in cardiac xenografts: clues to the pathogenesis of acute vascular rejection,” Transplantation, vol. 69, no. 4, pp. 475–482, 2000. View at Google Scholar · View at Scopus
  65. E. Dejana, “Endothelial cell-cell junctions: happy together,” Nature Reviews Molecular Cell Biology, vol. 5, no. 4, pp. 261–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. G. Bazzoni and E. Dejana, “Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis,” Physiological Reviews, vol. 84, no. 3, pp. 869–901, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. M. G. Farquhar and G. E. Palade, “Junctional complexes in various epithelia,” The Journal of Cell Biology, vol. 17, pp. 375–412, 1963. View at Google Scholar · View at Scopus
  68. G. van Meer, B. Gumbiner, and K. Simons, “The tight junction does not allow lipid molecules to diffuse from one epithelial cell to the next,” Nature, vol. 322, no. 6080, pp. 639–641, 1986. View at Google Scholar · View at Scopus
  69. E. A. Runkle and D. Mu, “Tight junction proteins: from barrier to tumorigenesis,” Cancer Letters, vol. 337, no. 1, pp. 41–48, 2013. View at Publisher · View at Google Scholar
  70. G. Bazzoni, “The JAM family of junctional adhesion molecules,” Current Opinion in Cell Biology, vol. 15, no. 5, pp. 525–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Ebnet, “Organization of multiprotein complexes at cell-cell junctions,” Histochemistry and Cell Biology, vol. 130, no. 1, pp. 1–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. D. Schulzke, D. Günzel, L. J. John, and M. Fromm, “Perspectives on tight junction research,” Annals of the New York Academy of Sciences, vol. 1257, pp. 1–19, 2012. View at Publisher · View at Google Scholar
  73. F. R. Curry and R. H. Adamson, “Tonic regulation of vascular permeability,” Acta Physiologica, vol. 207, no. 4, pp. 628–649, 2013. View at Publisher · View at Google Scholar
  74. E. Dejana and C. Giampietro, “Vascular endothelial-cadherin and vascular stability,” Current Opinion in Hematology, vol. 19, no. 3, pp. 218–223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Drexler, A. M. Zeiher, K. Meinzer, and H. Just, “Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine,” The Lancet, vol. 338, no. 8782-8783, pp. 1546–1550, 1991. View at Google Scholar · View at Scopus
  76. J.-P. Gratton, P. Bernatchez, and W. C. Sessa, “Caveolae and caveolins in the cardiovascular system,” Circulation Research, vol. 94, no. 11, pp. 1408–1417, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. C. J. Knowles, M. Dionne, M. Cebova, and I. M. Pinz, “Palmitate-induced translocation of caveolin-3 and endothelial nitric oxide synthase in cardiomyocytes,” Online Journal of Biological Sciences, vol. 11, no. 2, pp. 27–36, 2011. View at Google Scholar · View at Scopus
  78. G. Sowa, “Caveolae, caveolins, cavins, and endothelial cell function: new insights,” Frontiers in Physiology, vol. 2, article 120, 2012. View at Publisher · View at Google Scholar
  79. G. García-Cardeña, P. Martasek, B. S. S. Masters et al., “Dissecting the interaction between Nitric Oxide Synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo,” Journal of Biological Chemistry, vol. 272, no. 41, pp. 25437–25440, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. E. Sbaa, F. Frérart, and O. Feron, “The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis,” Trends in Cardiovascular Medicine, vol. 15, no. 5, pp. 157–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Saliez, C. Bouzin, G. Rath et al., “Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation-ca2+ signals and gap junction function are regulated by caveolin in endothelial cells,” Circulation, vol. 117, no. 8, pp. 1065–1074, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. P. N. Bernatcher, P. M. Bauer, J. Yu, J. S. Prendergast, P. He, and W. C. Sessa, “Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 3, pp. 761–766, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Murata, M. I. Lin, R. V. Stan, P. M. Bauer, J. Yu, and W. C. Sessa, “Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells,” Journal of Biological Chemistry, vol. 282, no. 22, pp. 16631–16643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Lockwich, B. B. Singh, X. Liu, and I. S. Ambudkar, “Stabilization of cortical actin induces internalization of Transient Receptor Potential 3 (Trp3)-associated caveolar Ca2+signaling complex and loss of Ca2+ influx without disruption of Trp3-inositol trisphosphate receptor association,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 42401–42408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. M. T. Nelson, Y. H. Yu Huang, J. E. Brayden, J. Hescheler, and N. B. Standen, “Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels,” Nature, vol. 344, no. 6268, pp. 770–773, 1990. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Félétou and P. M. Vanhoutte, “Endothelium-derived hyperpolarizing factor: where are we now?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. 1215–1225, 2006. View at Publisher · View at Google Scholar
  87. J.-F. Jasmin, P. G. Frank, and M. P. Lisanti, Caveolins and Caveolae—Roles in Signaling and Disease Mechanisms, Springer, 2012.
  88. H. Chen, J. Yang, P. S. Low, and J.-X. Cheng, “Cholesterol level regulates endosome motility via Rab proteins,” Biophysical Journal, vol. 94, no. 4, pp. 1508–1520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. O. Feron and J.-L. Balligand, “Caveolins and the regulation of endothelial nitric oxide synthase in the heart,” Cardiovascular Research, vol. 69, no. 4, pp. 788–797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Sowa, “Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function,” Biochemistry Research International, vol. 2011, Article ID 809259, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. D. J. Beech, “Characteristics of transient receptor potential canonical calcium-permeable channels and their relevance to vascular physiology and disease,” Circulation Journal, vol. 77, no. 3, pp. 570–579, 2013. View at Publisher · View at Google Scholar
  92. A. Dietrich, H. Kalwa, and T. Gudermann, “TRPC channels in vascular cell function,” Thrombosis and Haemostasis, vol. 103, no. 2, pp. 262–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Freichel, S. H. Suh, A. Pfeifer et al., “Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4−/− mice,” Nature Cell Biology, vol. 3, no. 2, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. T. Yoshida, R. Inoue, T. Morii et al., “Nitric oxide activates TRP channels by cysteine S-nitrosylation,” Nature Chemical Biology, vol. 2, no. 11, pp. 596–607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. P. Chaudhuri, S. M. Colles, D. S. Damron, and L. M. Graham, “Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 218–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. H.-Y. Kwan, Y. Huang, and X. Yao, “Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism,” Journal of Biological Chemistry, vol. 275, no. 10, pp. 6758–6163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. H.-Y. Kwan, Y. Huang, and X. Yao, “Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2625–2630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Poteser, A. Graziani, C. Rosker et al., “TRPC3 and TRPC4 associate to form a redox-sensitive cation channel: evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells,” Journal of Biological Chemistry, vol. 281, no. 19, pp. 13588–13595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. B. A. Miller and W. Zhang, “TRP channels as mediators of oxidative stress,” Advances in Experimental Medicine and Biology, vol. 704, pp. 531–544, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Chen, T. Masaki, and T. Sawamura, “LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis,” Pharmacology and Therapeutics, vol. 95, no. 1, pp. 89–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. P. E. Szmitko, C.-H. Wang, R. D. Weisel, G. A. Jeffries, T. J. Anderson, and S. Verma, “Biomarkers of vascular disease linking inflammation to endothelial activation part II,” Circulation, vol. 108, no. 17, pp. 2041–2048, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. I. Andreou, D. Tousoulis, C. Tentolouris, C. Antoniades, and C. Stefanadis, “Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives,” Atherosclerosis, vol. 189, no. 2, pp. 247–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. C. P. Lin, F. Y. Lin, P. H. Huang et al., “Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation,” BioMed Research International, vol. 2013, Article ID 845037, 10 pages, 2013. View at Publisher · View at Google Scholar
  104. A. Aicher, A. M. Zeiher, and S. Dimmeler, “Mobilizing endothelial progenitor cells,” Hypertension, vol. 45, no. 3, pp. 321–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Iwaguro, J.-I. Yamaguchi, C. Kalka et al., “Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration,” Circulation, vol. 105, no. 6, pp. 732–738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000. View at Google Scholar · View at Scopus
  107. C. Urbich, A. I. de Souza, L. Rossig et al., “Proteomic characterization of human early pro-angiogenic cells,” Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 333–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. M. E. J. Reinders, T. J. Rabelink, and D. M. Briscoe, “Angiogenesis and endothelial cell repair in renal disease and allograft rejection,” Journal of the American Society of Nephrology, vol. 17, no. 4, pp. 932–942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. J. P. Kirton and Q. Xu, “Endothelial precursors in vascular repair,” Microvascular Research, vol. 79, no. 3, pp. 193–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Vasa, S. Fichtlscherer, A. Aicher et al., “Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease,” Circulation Research, vol. 89, no. 1, pp. E1–E7, 2001. View at Google Scholar · View at Scopus
  111. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Rafii and D. Lyden, “Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration,” Nature Medicine, vol. 9, no. 6, pp. 702–712, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Gunsilius, H. C. Duba, A. L. Petzer, C. M. Kähler, and G. A. Gastl, “Contribution of endothelial cells of hematopoietic origin to blood vessel formation,” Circulation Research, vol. 88, no. 1, article E1, 2001. View at Google Scholar · View at Scopus
  114. P. Sarto, E. Balducci, G. Balconi et al., “Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 13, no. 9, pp. 701–708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. C. de Ciuceis, C. Rossini, E. Porteri et al., “Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery,” Blood Press, vol. 22, no. 3, pp. 165–172, 2013. View at Publisher · View at Google Scholar
  116. G. M. Rubanyi, “The role of endothelium in cardiovascular homeostasis and diseases,” Journal of Cardiovascular Pharmacology, vol. 22, supplement 4, pp. S1–S14, 1993. View at Google Scholar · View at Scopus
  117. P. M. Vanhoutte, “Regeneration of the endothelium in vascular injury,” Cardiovascular Drugs and Therapy, vol. 24, no. 4, pp. 299–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. M. S.-K. Wong and P. M. Vanhoutte, “COX-mediated endothelium-dependent contractions: from the past to recent discoveries,” Acta Pharmacologica Sinica, vol. 31, no. 9, pp. 1095–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Schrör, E. Bretschneider, K. Fischer et al., “Thrombin receptors in vascular smooth muscle cells—function and regulation by vasodilatory prostaglandins,” Thrombosis and Haemostasis, vol. 103, no. 5, pp. 884–890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. D. Kerage, D. N. Brindley, and D. G. Hemmings, “Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate,” Placenta, vol. 35, pp. S86–S92, 2014. View at Publisher · View at Google Scholar
  121. D. Feng, J. A. Nagy, K. Pyne, H. F. Dvorak, and A. M. Dvorak, “Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP,” Journal of Experimental Medicine, vol. 187, no. 6, pp. 903–915, 1998. View at Publisher · View at Google Scholar · View at Scopus
  122. C. V. Carman and T. A. Springer, “A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them,” The Journal of Cell Biology, vol. 167, no. 2, pp. 377–388, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. E. C. Butcher, “Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity,” Cell, vol. 67, no. 6, pp. 1033–1036, 1991. View at Google Scholar · View at Scopus
  124. M. Aurrand-Lions, C. Johnson-Leger, and B. A. Imhof, “The last molecular fortress in leukocyte trans-endothelial migration,” Nature Immunology, vol. 3, no. 2, pp. 116–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  125. A. R. Pries and W. M. Kuebler, “Normal endothelium,” Handbook of Experimental Pharmacology, part 1, no. 176, pp. 1–40, 2006. View at Google Scholar · View at Scopus
  126. P. L. A. Giesen, U. Rauch, B. Bohrmann et al., “Blood-borne tissue factor: another view of thrombosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2311–2315, 1999. View at Publisher · View at Google Scholar · View at Scopus
  127. W. C. Aird, “Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis,” Critical Care Medicine, vol. 29, supplement 7, pp. S28–S35, 2001. View at Google Scholar · View at Scopus
  128. Z. Laszik, A. Mitro, F. B. Taylor Jr., G. Ferrell, and C. T. Esmon, “Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway,” Circulation, vol. 96, no. 10, pp. 3633–3640, 1997. View at Google Scholar · View at Scopus
  129. H. Ishii, H. H. Salem, and C. E. Bell, “Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain,” Blood, vol. 67, no. 2, pp. 362–365, 1986. View at Google Scholar · View at Scopus
  130. W. C. Aird, “Endothelial cell heterogeneity,” Critical Care Medicine, vol. 31, supplement 4, pp. S221–S230, 2003. View at Google Scholar · View at Scopus
  131. S. Verma and T. J. Anderson, “Fundamentals of endothelial function for the clinical cardiologist,” Circulation, vol. 105, no. 5, pp. 546–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. R. Ross and J. A. Glomset, “Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis,” Science, vol. 180, no. 4093, pp. 1332–1339, 1973. View at Google Scholar · View at Scopus
  133. W. C. Aird, “Spatial and temporal dynamics of the endothelium,” Journal of Thrombosis and Haemostasis, vol. 3, no. 7, pp. 1392–1406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. J. S. Pober and R. S. Cotran, “Cytokines and endothelial cell biology,” Physiological Reviews, vol. 70, no. 2, pp. 427–451, 1990. View at Google Scholar · View at Scopus
  135. W. Weninger, L. H. Ulfman, G. Cheng et al., “Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels,” Immunity, vol. 12, no. 6, pp. 665–676, 2000. View at Google Scholar · View at Scopus
  136. J. A. Suwaidi, S. Hamasaki, S. T. Higano, R. A. Nishimura, D. R. Holmes Jr., and A. Lerman, “Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction,” Circulation, vol. 101, no. 9, pp. 948–954, 2000. View at Google Scholar · View at Scopus
  137. V. Schächinger, M. B. Britten, and A. M. Zeiher, “Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease,” Circulation, vol. 101, no. 16, pp. 1899–1906, 2000. View at Google Scholar · View at Scopus
  138. H. Shimokawa, “Primary endothelial dysfunction: atherosclerosis,” Journal of Molecular and Cellular Cardiology, vol. 31, no. 1, pp. 23–37, 1999. View at Publisher · View at Google Scholar · View at Scopus
  139. I. Ertenli, S. Kiraz, M. A. Öztürk et al., “Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever,” Rheumatology International, vol. 20, no. 6, pp. 217–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  140. J. L. Mehta and D. Li, “Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor,” Journal of the American College of Cardiology, vol. 39, no. 9, pp. 1429–1435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Yoshida, N. Kondratenko, S. Green, D. Steinberg, and O. Quehenberger, “Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor,” Biochemical Journal, vol. 334, part 1, pp. 9–13, 1998. View at Google Scholar · View at Scopus
  142. T. Aoyama, M. Chen, H. Fujiwara, T. Masaki, and T. Sawamura, “LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells,” FEBS Letters, vol. 467, no. 2-3, pp. 217–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Mitra, T. Goyal, and J. L. Mehta, “Oxidized LDL, LOX-1 and atherosclerosis,” Cardiovascular Drugs and Therapy, vol. 25, no. 5, pp. 419–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Honjo, K. Nakamura, K. Yamashiro et al., “Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1274–1279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Cominacini, A. F. Pasini, U. Garbin et al., “The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells,” Journal of the American College of Cardiology, vol. 41, no. 3, pp. 499–507, 2003. View at Publisher · View at Google Scholar · View at Scopus
  146. M. Chen, M. Kakutani, M. Minami et al., “Increased expression of lectinlike oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 1107–1115, 2000. View at Google Scholar · View at Scopus
  147. D. Y. Li, H. J. Chen, E. D. Staples et al., “Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 7, no. 3, pp. 147–153, 2002. View at Google Scholar · View at Scopus
  148. M. Yan, J. L. Mehta, W. Zhang, and C. Hu, “LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications,” Cardiovascular Drugs and Therapy, vol. 25, no. 5, pp. 451–459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. H. Chen, D. Li, T. Saldeen, and J. L. Mehta, “Transforming growth factor-β1 modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1,” Circulation Research, vol. 89, no. 12, pp. 1155–1160, 2001. View at Google Scholar · View at Scopus
  150. X. Wang, M. I. Phillips, and J. L. Mehta, “LOX-1 and angiotensin receptors, and their interplay,” Cardiovascular Drugs and Therapy, vol. 25, no. 5, pp. 401–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. D. Li and J. L. Mehta, “Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells,” Circulation, vol. 101, no. 25, pp. 2889–2895, 2000. View at Google Scholar · View at Scopus
  152. D. Li and J. L. Mehta, “Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 4, pp. 1116–1122, 2000. View at Google Scholar · View at Scopus
  153. M. Kakutani, T. Masaki, and T. Sawamura, “A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 1, pp. 360–364, 2000. View at Google Scholar · View at Scopus
  154. A. Rahman, A. L. True, K. N. Anwar, R. D. Ye, T. A. Voyno-Yasenetskaya, and A. B. Malik, “Gαq and Gβγ regulate PAR-1 signaling of thrombin-induced NF-κB activation and ICAM-1 transcription in endothelial cells,” Circulation Research, vol. 91, no. 5, pp. 398–405, 2002. View at Publisher · View at Google Scholar · View at Scopus
  155. S. W. Klarenbach, A. Chipiuk, R. C. Nelson, M. D. Hollenberg, and A. G. Murray, “Differential actions of PAR2 and PAR1, in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases,” Circulation Research, vol. 92, no. 3, pp. 272–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  156. L. Chi, Y. Li, L. Stehno-Bittel et al., “Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-α,” Journal of Interferon and Cytokine Research, vol. 21, no. 4, pp. 231–240, 2001. View at Publisher · View at Google Scholar · View at Scopus
  157. A. M. Zeiher, H. Drexler, H. Wollschlager, and H. Just, “Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis,” Circulation, vol. 83, no. 2, pp. 391–401, 1991. View at Google Scholar · View at Scopus
  158. A. M. Zeiher, H. Drexler, B. Saurbier, and H. Just, “Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension,” Journal of Clinical Investigation, vol. 92, no. 2, pp. 652–662, 1993. View at Google Scholar · View at Scopus
  159. M. A. Creager, J. P. Cooke, M. E. Mendelsohn et al., “Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans,” Journal of Clinical Investigation, vol. 86, no. 1, pp. 228–234, 1990. View at Google Scholar · View at Scopus
  160. R. J. Esper, R. Machado, J. Vilarino et al., “Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined,” American Heart Journal, vol. 140, no. 4, pp. 684–689, 2000. View at Publisher · View at Google Scholar · View at Scopus
  161. R. A. Vogel, M. C. Corretti, and J. Gellman, “Cholesterol, cholesterol lowering, and endothelial function,” Progress in Cardiovascular Diseases, vol. 41, no. 2, pp. 117–136, 1998. View at Publisher · View at Google Scholar · View at Scopus
  162. W.-H. Leung, C.-P. Lau, and C.-K. Wong, “Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients,” The Lancet, vol. 341, no. 8859, pp. 1496–1500, 1993. View at Publisher · View at Google Scholar · View at Scopus
  163. B. Hornig, V. Maier, and H. Drexler, “Physical training improves endothelial function in patients with chronic heart failure,” Circulation, vol. 93, no. 2, pp. 210–214, 1996. View at Google Scholar · View at Scopus
  164. D. S. Celermajer, K. E. Sorensen, D. Georgakopoulos et al., “Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults,” Circulation, vol. 88, no. 5, part 1, pp. 2149–2155, 1993. View at Google Scholar · View at Scopus
  165. D. Urban, S. Ewen, C. Ukena, D. Linz, M. Böhm, and F. Mahfoud, “Treating resistant hypertension: role of renal denervation,” Integrated Blood Pressure Control, vol. 6, pp. 119–128, 2013. View at Google Scholar
  166. J. Ketonen, J. Shi, E. Martonen, and E. Mervaala, “Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BL/6 mice,” Circulation Journal, vol. 74, no. 7, pp. 1479–1487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. C. Lu, A. X. Zhao, Y.-J. Gao, and R. M. Lee, “Modulation of vein function by perivascular adipose tissue,” European Journal of Pharmacology, vol. 657, no. 1–3, pp. 111–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  168. A. S. Greenstein, K. Khavandi, S. B. Withers et al., “Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients,” Circulation, vol. 119, no. 12, pp. 1661–1670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. T. Szasz, G. F. Bomfim, and R. C. Webb, “The influence of perivascular adipose tissue on vascular homeostasis,” Journal of Vascular Health and Risk Management, vol. 9, pp. 105–116, 2013. View at Google Scholar
  170. F. M. Lynch, S. B. Withers, Z. Yao et al., “Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses,” American Journal of Physiology, vol. 304, no. 6, pp. H786–H795, 2013. View at Google Scholar
  171. Y.-J. Gao, Z.-H. Zeng, K. Teoh et al., “Perivascular adipose tissue modulates vascular function in the human internal thoracic artery,” Journal of Thoracic and Cardiovascular Surgery, vol. 130, no. 4, pp. 1130–1136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  172. R. M. Lee, C. Lu, L.-Y. Su, and Y.-J. Gao, “Endothelium-dependent relaxation factor released by perivascular adipose tissue,” Journal of Hypertension, vol. 27, no. 4, pp. 782–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  173. B. Gálvez-Prieto, B. Somoza, M. Gil-Ortega et al., “Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension,” Frontiers in Pharmacology, vol. 3, article 103, 2012. View at Publisher · View at Google Scholar
  174. Y. Higashi, S. Sukhanov, A. Anwar, S. Y. Shai, and P. Delafontaine, “Aging, atherosclerosis, and IGF-1,” The Journals of Gerontology A, vol. 67, no. 6, pp. 626–639, 2012. View at Google Scholar
  175. M. A. Newaz and N. N. A. Nawal, “Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats,” American Journal of Hypertension, vol. 11, no. 12, pp. 1480–1485, 1998. View at Publisher · View at Google Scholar · View at Scopus
  176. R. Rezzani, E. Porteri, C. de Ciuceis et al., “Effects of melatonin and pycnogenol on small artery structure and function in spontaneously hypertensive rats,” Hypertension, vol. 55, no. 6, pp. 1373–1380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. L. F. Rodella, G. Favero, E. Foglio et al., “Vascular endothelial cells and dysfunctions: role of melatonin,” Frontiers in Bioscience, vol. 5, pp. 119–129, 2013. View at Google Scholar
  178. C. M. Kolka and R. N. Bergman, “The endothelium in diabetes: its role in insulin access and diabetic complications,” Reviews in Endocrine and Metabolic Disorders, vol. 14, no. 1, pp. 13–19, 2013. View at Publisher · View at Google Scholar
  179. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  180. R. T. de Jongh, E. H. Serné, R. G. Ijzerman, G. de Vries, and C. D. A. Stehouwer, “Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance,” Circulation, vol. 109, no. 21, pp. 2529–2535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  181. A. E. Caballero, S. Arora, R. Saouaf et al., “Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes,” Diabetes, vol. 48, no. 9, pp. 1856–1862, 1999. View at Publisher · View at Google Scholar · View at Scopus
  182. E. C. Eringa, C. D. A. Stehouwer, M. H. Roos, N. Westerhof, and P. Sipkema, “Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats,” American Journal of Physiology, vol. 293, no. 5, pp. E1134–E1139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  183. E. B. Okon, A. W. Y. Chung, P. Rauniyar et al., “Compromised arterial function in human type 2 diabetic patients,” Diabetes, vol. 54, no. 8, pp. 2415–2423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  184. R. I. Meijer, M. P. de Boer, M. R. Groen et al., “Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake,” Microcirculation, vol. 19, no. 6, pp. 494–500, 2012. View at Publisher · View at Google Scholar
  185. E. Kostromina, N. Gustavsson, X. Wang et al., “Glucose intolerance and impaired insulin secretion in pancreas-specific signal transducer and activator of transcription-3 knockout mice are associated with microvascular alterations in the pancreas,” Endocrinology, vol. 151, no. 5, pp. 2050–2059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  186. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Google Scholar · View at Scopus
  187. R. Prakash, P. R. Somanath, A. B. El-Remessy et al., “Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling,” Diabetes, vol. 61, no. 6, pp. 1533–1542, 2012. View at Publisher · View at Google Scholar
  188. S. C. Chang and W. C. V. Yang, “Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 457971, 11 pages, 2013. View at Publisher · View at Google Scholar
  189. K. H. Elçioǧlu, L. Kabasakal, Ş. Çetinel, G. Conturk, S. F. Sezen, and G. Ayanoǧlu-Dülger, “Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats,” European Journal of Pharmacology, vol. 642, no. 1–3, pp. 113–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  190. E. N. Zeydanli, H. B. Kandilci, and B. Turan, “Doxycycline ameliorates vascular endothelial and contractile dysfunction in the thoracic aorta of diabetic rats,” Cardiovascular Toxicology, vol. 11, no. 2, pp. 134–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  191. S. M. Shenouda, M. E. Widlansky, K. Chen et al., “Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus,” Circulation, vol. 124, no. 4, pp. 444–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  192. A. B. Goldfine, J. A. Beckman, R. A. Betensky et al., “Family history of diabetes is a major determinant of endothelial function,” Journal of the American College of Cardiology, vol. 47, no. 12, pp. 2456–2461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  193. R. I. Meijer, E. H. Serne, Y. M. Smulders, V. W. M. van Hinsbergh, J. S. Yudkin, and E. C. Eringa, “Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease,” Current Diabetes Reports, vol. 11, no. 3, pp. 211–217, 2011. View at Publisher · View at Google Scholar · View at Scopus
  194. S. Hagita, M. Osaka, K. Shimokado, and M. Yoshida, “Adipose inflammation initiates recruitment of leukocytes to mouse femoral artery: role of adipo-vascular axis in chronic inflammation,” PLoS ONE, vol. 6, no. 5, Article ID e19871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  195. F. Kim, M. Pham, E. Maloney et al., “Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1982–1988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  196. E. C. Eringa, C. D. A. Stehouwer, K. Walburg et al., “Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-α dependence on c-Jun N-terminal kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 274–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  197. W. Bakker, P. Sipkema, C. D. A. Stehouwer et al., “Protein kinase C θ activation induces insulin-mediated constriction of muscle resistance arteries,” Diabetes, vol. 57, no. 3, pp. 706–713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  198. R. I. Meijer, W. Bakker, C. L. Alta et al., “Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice,” Diabetes, vol. 62, no. 2, pp. 590–598, 2013. View at Publisher · View at Google Scholar
  199. C. Rask-Madsen, H. Domínguez, N. Ihlemann, T. Hermann, L. Køber, and C. Torp-Pedersen, “Tumor necrosis factor-α inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans,” Circulation, vol. 108, no. 15, pp. 1815–1821, 2003. View at Publisher · View at Google Scholar · View at Scopus
  200. A. J. Houben, E. C. Eringa, A. M. Jonk, E. H. Serne, Y. M. Smulders, and C. D. Stehouwer, “Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease,” Current Cardiovascular Risk Reports, vol. 6, no. 1, pp. 80–90, 2012. View at Publisher · View at Google Scholar
  201. T. K. Chatterjee, L. L. Stoll, G. M. Denning et al., “Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding,” Circulation Research, vol. 104, no. 4, pp. 541–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  202. E. Henrichot, C. E. Juge-Aubry, A. Pernin et al., “Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2594–2599, 2005. View at Publisher · View at Google Scholar · View at Scopus
  203. S. B. Withers, C. Agabiti-Rosei, D. M. Livingstone et al., “Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 908–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  204. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  205. J. Yin, Z. Gao, Q. He, D. Zhou, Z. Guo, and J. Ye, “Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue,” American Journal of Physiology, vol. 296, no. 2, pp. E333–E342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  206. N. K. Ghaisas, J. B. Foley, D. S. O'Briain, P. Crean, D. Kelleher, and M. Walsh, “Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement,” Journal of the American College of Cardiology, vol. 36, no. 7, pp. 2257–2262, 2000. View at Publisher · View at Google Scholar · View at Scopus
  207. A. M. Müller, C. Cronen, L. I. Kupferwasser, H. Oelert, K. M. Müller, and C. J. Kirkpatrick, “Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis,” Journal of Pathology, vol. 191, no. 1, pp. 54–60, 2000. View at Google Scholar
  208. F. Chalajour, H. Treede, A. Ebrahimnejad, H. Lauke, H. Reichenspurner, and S. Ergun, “Angiogenic activation of valvular endothelial cells in aortic valve stenosis,” Experimental Cell Research, vol. 298, no. 2, pp. 455–464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  209. J. P. J. Halcox and A. A. Quyyumi, “Coronary vascular endothelial function and myocardial ischemia: why should we worry about endothelial dysfunction?” Coronary Artery Disease, vol. 12, no. 6, pp. 475–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  210. J. F. Argacha, D. Fontaine, D. Adamopoulos et al., “Acute effect of sidestream cigarette smoke extract on vascular endothelial function,” Journal of Cardiovascular Pharmacology, vol. 52, no. 3, pp. 262–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  211. P. Balakumar, R. Sharma, and M. Singh, “Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat,” Pharmacological Research, vol. 58, no. 5-6, pp. 356–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  212. S. C. Campbell, R. J. Moffatt, and B. A. Stamford, “Smoking and smoking cessation—the relationship between cardiovascular disease and lipoprotein metabolism: a review,” Atherosclerosis, vol. 201, no. 2, pp. 225–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  213. P. Balakumar and J. Kaur, “Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?” Pharmacological Research, vol. 60, no. 5, pp. 361–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  214. R. M. Pittilo, “Cigarette smoking and endothelial injury: a review,” Advances in Experimental Medicine and Biology, vol. 273, pp. 61–78, 1990. View at Google Scholar · View at Scopus
  215. D. Bernhard, A. Rossmann, and G. Wick, “Metals in cigarette smoke,” IUBMB Life, vol. 57, no. 12, pp. 805–809, 2005. View at Publisher · View at Google Scholar · View at Scopus
  216. M. M. Rahman and I. Laher, “Structural and functional alteration of blood vessels caused by cigarette smoking: an overiew of molecular mechanisms,” Current Vascular Pharmacology, vol. 5, no. 4, pp. 276–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  217. H.-L. Luo, W.-J. Zang, J. Lu, X.-J. Yu, Y.-X. Lin, and Y.-X. Cao, “The protective effect of captopril on nicotine-induced endothelial dysfunction in rat,” Basic and Clinical Pharmacology and Toxicology, vol. 99, no. 3, pp. 237–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  218. C. R. W. Kuhlmann, J. R. F. C. Trümper, H. Tillmanns, C. A. Schaefer, and A. Erdogan, “Nicotine inhibits large conductance Ca2+-activated K+ channels and the NO/-cGMP signaling pathway in cultured human endothelial cells,” Scandinavian Cardiovascular Journal, vol. 39, no. 6, pp. 348–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  219. L. Erhardt, “Cigarette smoking: an undertreated risk factor for cardiovascular disease,” Atherosclerosis, vol. 205, no. 1, pp. 23–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  220. L. F. Rodella, C. Rossini, G. Favero, E. Foglio, C. Loreto, and R. Rezzani, “Nicotine-induced morphological changes in rat aorta: the protective role of melatonin,” Cells Tissues Organs, vol. 195, no. 3, pp. 252–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  221. L. F. Rodella, G. Favero, C. Rossini, E. Foglio, R. J. Reiter, and R. Rezzani, “Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy,” Life Sciences, vol. 87, no. 17-18, pp. 558–564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  222. X. L. Wang, M. Raveendran, and J. Wang, “Genetic influence on cigarette-induced cardiovascular disease,” Progress in Cardiovascular Diseases, vol. 45, no. 5, pp. 361–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  223. M. D. Herrera, C. Mingorance, R. Rodríguez-Rodríguez, and M. A. de Sotomayor, “Endothelial dysfunction and aging: an update,” Ageing Research Reviews, vol. 9, no. 2, pp. 142–152, 2010. View at Publisher · View at Google Scholar
  224. A. U. Ferrari, A. Radaelli, and M. Centola, “Invited review: aging and the cardiovascular system,” Journal of Applied Physiology, vol. 95, no. 6, pp. 2591–2597, 2003. View at Google Scholar · View at Scopus
  225. R. L. Matz and R. Andriantsitohaina, “Age-related endothelial dysfunction: potential implications for pharmacotherapy,” Drugs and Aging, vol. 20, no. 7, pp. 527–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  226. R. P. Brandes, I. Fleming, and R. Busse, “Endothelial aging,” Cardiovascular Research, vol. 66, no. 2, pp. 286–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  227. A. A. Puca, A. Carrizzo, F. Villa et al., “Vascular ageing: the role of oxidative stress,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 3, pp. 556–559, 2013. View at Publisher · View at Google Scholar
  228. S. M. L. Wallace, Y. Yasmin, C. M. McEniery et al., “Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction,” Hypertension, vol. 50, no. 1, pp. 228–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  229. A. Csiszar, J. Toth, J. Peti-Peterdi, and Z. Ungvari, “The aging kidney: role of endothelial oxidative stress and inflammation,” Acta Physiologica Hungarica, vol. 94, no. 1-2, pp. 107–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  230. J. M. Price, A. Hellermann, G. Hellermann, and E. T. Sutton, “Aging enhances vascular dysfunction induced by the Alzheimer's peptide β-amyloid,” Neurological Research, vol. 26, no. 3, pp. 305–311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  231. T. Kunieda, T. Minamino, K. Miura et al., “Reduced nitric oxide causes age-associated impairment of circadian rhythmicity,” Circulation Research, vol. 102, no. 5, pp. 607–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  232. A. L. Burnett, “The role of nitric oxide in erectile dysfunction: implications for medical therapy,” Journal of Clinical Hypertension, vol. 8, supplement 4, no. 12, pp. 53–62, 2006. View at Google Scholar · View at Scopus
  233. M. Sanada, A. Taguchi, Y. Higashi et al., “Forearm endothelial function and bone mineral loss in postmenopausal women,” Atherosclerosis, vol. 176, no. 2, pp. 387–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  234. H. R. Coleman, C.-C. Chan, F. L. Ferris III, and E. Y. Chew, “Age-related macular degeneration,” The Lancet, vol. 372, no. 9652, pp. 1835–1845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  235. P. E. Gates, W. D. Strain, and A. C. Shore, “Human endothelial function and microvascular ageing,” Experimental Physiology, vol. 94, no. 3, pp. 311–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  236. J. Lähteenvuo and A. Rosenzweig, “Effects of aging on angiogenesis,” Circulation Research, vol. 110, no. 9, pp. 1252–1264, 2012. View at Publisher · View at Google Scholar
  237. T. Finkel, “Oxidant signals and oxidative stress,” Current Opinion in Cell Biology, vol. 15, no. 2, pp. 247–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  238. C. Vecchione and R. P. Brandes, “Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice,” Circulation Research, vol. 91, no. 2, pp. 173–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  239. Z. Ungvari, L. Bailey-Downs, D. Sosnowska et al., “Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response,” American Journal of Physiology, vol. 301, no. 2, pp. H363–H372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  240. D.-F. Dai, P. S. Rabinovitch, and Z. Ungvari, “Mitochondria and cardiovascular aging,” Circulation Research, vol. 110, no. 8, pp. 1109–1124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  241. B. L. Tang, “Sirt1's systemic protective roles and its promise as a target in antiaging medicine,” Translational Research, vol. 157, no. 5, pp. 276–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  242. S. Chung, H. Yao, S. Caito, J.-W. Hwang, G. Arunachalam, and I. Rahman, “Regulation of SIRT1 in cellular functions: role of polyphenols,” Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 79–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  243. A. M. Cuevas and A. M. Germain, “Diet and endothelial function,” Biological Research, vol. 37, no. 2, pp. 225–230, 2004. View at Google Scholar · View at Scopus
  244. S.-I. Yamagishi, T. Matsui, and K. Nakamura, “Atheroprotective properties of Pigment Epithelium-Derived Factor (PEDF) in cardiometabolic disorders,” Current Pharmaceutical Design, vol. 15, no. 9, pp. 1027–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  245. D. Ziegler, “Type 2 diabetes as an inflammatory cardiovascular disorder,” Current Molecular Medicine, vol. 5, no. 3, pp. 309–322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  246. J. Szostak and P. Laurant, “The forgotten face of regular physical exercise: a “natural” anti-atherogenic activity,” Clinical Science, vol. 121, no. 3, pp. 91–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  247. M. D. Brown and D. L. Feairheller, “Are there race-dependent endothelial cell responses to exercise?” Exercise & Sport Sciences Reviews, vol. 41, no. 1, pp. 44–54, 2013. View at Publisher · View at Google Scholar
  248. K. E. Flynn, I. L. Piña, D. J. Whellan et al., “Effects of exercise training on health status in patients with chronic heart failure HF-ACTION randomized controlled trial,” Journal of the American Medical Association, vol. 301, no. 14, pp. 1451–1459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  249. J. Downing and G. J. Balady, “The role of exercise training in heart failure,” Journal of the American College of Cardiology, vol. 58, no. 6, pp. 561–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  250. J. Niebauer, “Effects of exercise training on inflammatory markers in patients with heart failure,” Heart Failure Reviews, vol. 13, no. 1, pp. 39–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  251. K. C. Miranda, T. Huynh, Y. Tay et al., “A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes,” Cell, vol. 126, no. 6, pp. 1203–1217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  252. M. M. Fernandes-Silva, V. O. Carvalho, G. V. Guimarães, F. Bacal, and E. A. Bocchi, “Physical exercise and microRNAs: new frontiers in heart failure,” Arquivos Brasileiros de Cardiologia, vol. 98, no. 5, pp. 459–466, 2012. View at Publisher · View at Google Scholar
  253. R. A. Vogel, “The Mediterranean diet and endothelial function: why some dietary fats may be healthy,” Cleveland Clinic Journal of Medicine, vol. 67, no. 4, article 232, pp. 235–236, 2000, Erratum in Cleveland Clinic Journal of Medicine, vol. 67, no. 7, article 467, 2000. View at Google Scholar
  254. N. Nicolaïew, N. Lemort, L. Adorni et al., “Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation,” Annals of Nutrition and Metabolism, vol. 42, no. 5, pp. 251–260, 1998. View at Publisher · View at Google Scholar · View at Scopus
  255. E. Lopez-Garcia, M. B. Schulze, J. B. Meigs et al., “Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction,” Journal of Nutrition, vol. 135, no. 3, pp. 562–566, 2005. View at Google Scholar · View at Scopus
  256. J. M. Silva and C. Saldanha, “Diet, atherosclerosis and atherothrombotic events,” Revista Portuguesa de Cardiologia, vol. 26, no. 3, pp. 277–294, 2007. View at Google Scholar · View at Scopus
  257. F. B. Hu, J. E. Manson, and W. C. Willett, “Types of dietary fat and risk of coronary heart disease: a critical review,” Journal of the American College of Nutrition, vol. 20, no. 1, pp. 5–19, 2001. View at Google Scholar · View at Scopus
  258. D. Mozaffarian, “Trans fatty acids—effects on systemic inflammation and endothelial function,” Atherosclerosis Supplements, vol. 7, no. 2, pp. 29–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  259. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  260. R. Estruch, M. A. Martínez-González, D. Corella et al., “Effects of a Mediterranean-style diet on cardiovascular risk factors a randomized trial,” Annals of Internal Medicine, vol. 145, no. 1, pp. 1–11, 2006. View at Google Scholar · View at Scopus
  261. M. Ryan, D. Mcinerney, D. Owens, P. Collins, A. Johnson, and G. H. Tomkin, “Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity,” Monthly Journal of the Association of Physicians, vol. 93, no. 2, pp. 85–91, 2000. View at Google Scholar · View at Scopus
  262. M. de Lorgeril, P. Salen, J.-L. Martin, I. Monjaud, J. Delaye, and N. Mamelle, “Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart study,” Circulation, vol. 99, no. 6, pp. 779–785, 1999. View at Google Scholar · View at Scopus
  263. W. J. E. Bemelmans, J. D. Lefrandt, E. J. M. Feskens et al., “Change in saturated fat intake is associated with progression of carotid and femoral intima-media thickness, and with levels of soluble intercellular adhesion molecule-1,” Atherosclerosis, vol. 163, no. 1, pp. 113–120, 2002. View at Publisher · View at Google Scholar · View at Scopus
  264. A. Michalsen, N. Lehmann, C. Pithan et al., “Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease,” European Journal of Clinical Nutrition, vol. 60, no. 4, pp. 478–485, 2006. View at Publisher · View at Google Scholar · View at Scopus
  265. P. J. L. Ong, T. S. Dean, C. S. Hayward, P. L. D. Monica, T. A. B. Sanders, and P. Collins, “Effect of fat and carbohydrate consumption on endothelial function,” The Lancet, vol. 354, no. 9196, article 2134, 1999. View at Google Scholar · View at Scopus
  266. B. Khalfoun, G. Thibault, P. Bardos, and Y. Lebranchu, “Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion,” Transplantation, vol. 62, no. 11, pp. 1649–1657, 1996. View at Publisher · View at Google Scholar · View at Scopus
  267. C. T. Kappagoda, D. A. Hyson, and E. A. Amsterdam, “Low-carbohydrate-high-protein diets: is there a place for them in clinical cardiology?” Journal of the American College of Cardiology, vol. 43, no. 5, pp. 725–730, 2004. View at Publisher · View at Google Scholar · View at Scopus
  268. E. C. Westman, W. S. Yancy Jr., M. K. Olsen, T. Dudley, and J. R. Guyton, “Effect of a low-carbohydrate, ketogenic diet program compared to a low-fat diet on fasting lipoprotein subclasses,” International Journal of Cardiology, vol. 110, no. 2, pp. 212–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  269. W. E. Connor and S. L. Connor, “Should a low-fat, high-carbohydrate diet be recommended for everyone?” The New England Journal of Medicine, vol. 337, no. 8, pp. 562–563, 1997. View at Publisher · View at Google Scholar · View at Scopus
  270. M. B. Katan, S. M. Grundy, and W. C. Willett, “Beyond low-fat diets,” The New England Journal of Medicine, vol. 337, no. 8, pp. 563–566, 1997. View at Google Scholar · View at Scopus
  271. S. L. Weinberg, “The diet-heart hypothesis: a critique,” Journal of the American College of Cardiology, vol. 43, no. 5, pp. 731–733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  272. R. Landberg, N. Naidoo, and R. M. van Dam, “Diet and endothelial function: from individual components to dietary patterns,” Current Opinion in Lipidology, vol. 23, no. 2, pp. 147–155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  273. R. A. Vogel, M. C. Corretti, and G. D. Plotnick, “Effect of a single high-fat meal on endothelial function in healthy subjects,” American Journal of Cardiology, vol. 79, no. 3, pp. 350–354, 1997. View at Publisher · View at Google Scholar · View at Scopus
  274. C. Marin, R. Ramirez, J. Delgado-Lista et al., “Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium,” American Journal of Clinical Nutrition, vol. 93, no. 2, pp. 267–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  275. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod, “Nitric oxide release accounts for insulin's vascular effects in humans,” Journal of Clinical Investigation, vol. 94, no. 6, pp. 2511–2515, 1994. View at Google Scholar · View at Scopus
  276. F. Pérez-Jiménez, P. Castro, J. López-Miranda et al., “Circulating levels of endothelial function are modulated by dietary monounsaturated fat,” Atherosclerosis, vol. 145, no. 2, pp. 351–358, 1999. View at Publisher · View at Google Scholar
  277. F. Fuentes, J. López-Miranda, E. Sánchez et al., “Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men,” Annals of Internal Medicine, vol. 134, no. 12, pp. 1115–1119, 2001. View at Publisher · View at Google Scholar
  278. F. Leighton, S. Miranda-Rottmann, and I. Urquiaga, “A central role of eNOS in the protective effect of wine against metabolic syndrome,” Cell Biochemistry and Function, vol. 24, no. 4, pp. 291–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  279. D. Grassi, G. Desideri, and C. Ferri, “Flavonoids: antioxidants against atherosclerosis,” Nutrients, vol. 2, no. 8, pp. 889–902, 2010. View at Publisher · View at Google Scholar · View at Scopus
  280. R. Rezzani, L. F. Rodella, S. Tengattini et al., “Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy,” Journal of Histochemistry and Cytochemistry, vol. 54, no. 8, pp. 923–932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  281. A. T. Dinkova-Kostova and P. Talalay, “Direct and indirect antioxidant properties of inducers of cytoprotective proteins,” Molecular Nutrition and Food Research, vol. 52, supplement 1, pp. S128–S138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  282. A. T. Dinkova-Kostova, J. Cheah, A. Samouilov et al., “Phenolic Michael reaction acceptors: combined direct and indirect antioxidant defenses against electrophiles and oxidants,” Medicinal Chemistry, vol. 3, no. 3, pp. 261–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  283. M.-L. Hu, “Dietary polyphenols as antioxidants and anticancer agents: more questions than answers,” Chang Gung Medical Journal, vol. 34, no. 5, pp. 449–460, 2011. View at Google Scholar · View at Scopus
  284. B. Holst and G. Williamson, “Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants,” Current Opinion in Biotechnology, vol. 19, no. 2, pp. 73–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  285. L. Badimon, G. Vilahur, and T. Padro, “Nutraceuticals and atherosclerosis: human trials,” Cardiovascular Therapeutics, vol. 28, no. 4, pp. 202–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  286. M. Kyaw, M. Yoshizumi, K. Tsuchiya, Y. Izawa, Y. Kanematsu, and T. Tamaki, “Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases,” Acta Pharmacologica Sinica, vol. 25, no. 8, pp. 977–985, 2004. View at Google Scholar · View at Scopus
  287. R. Rezzani, S. Tengattini, F. Bonomini et al., “Red wine polyphenols prevent cyclosporine-induced nephrotoxicity at the level of the intrinsic apoptotic pathway,” Physiological Research, vol. 58, no. 4, pp. 511–519, 2009. View at Google Scholar · View at Scopus
  288. C. Morand, C. Dubray, D. Milenkovic et al., “Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers,” American Journal of Clinical Nutrition, vol. 93, no. 1, pp. 73–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  289. S. J. Duffy, J. F. Keaney Jr., M. Holbrook et al., “Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease,” Circulation, vol. 104, no. 2, pp. 151–156, 2001. View at Google Scholar · View at Scopus
  290. M.-I. Covas, “Olive oil and the cardiovascular system,” Pharmacological Research, vol. 55, no. 3, pp. 175–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  291. J. S. Perona, R. Cabello-Moruno, and V. Ruiz-Gutierrez, “The role of virgin olive oil components in the modulation of endothelial function,” Journal of Nutritional Biochemistry, vol. 17, no. 7, pp. 429–445, 2006. View at Publisher · View at Google Scholar · View at Scopus
  292. D. J. Hausenloy and D. M. Yellon, “Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels,” Postgraduate Medical Journal, vol. 84, no. 997, pp. 590–598, 2008. View at Google Scholar · View at Scopus
  293. M. A. Carluccio, M. Massaro, E. Scoditti, and R. de Caterina, “Vasculoprotective potential of olive oil components,” Molecular Nutrition and Food Research, vol. 51, no. 10, pp. 1225–1234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  294. A. Marquez-Martin, R. D. L. Puerta, A. Fernandez-Arche, V. Ruiz-Gutierrez, and P. Yaqoob, “Modulation of cytokine secretion by pentacyclic triterpenes from olive pomace oil in human mononuclear cells,” Cytokine, vol. 36, no. 5-6, pp. 211–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  295. U. Simonsen, R. Rodriguez-Rodriguez, T. Dalsgaard, N. H. Buus, and E. Stankevicius, “Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation,” Pharmacological Reports, vol. 61, no. 1, pp. 105–115, 2009. View at Google Scholar · View at Scopus
  296. R. Masella, R. Varì, M. D'Archivio et al., “Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes,” Journal of Nutrition, vol. 134, no. 4, pp. 785–791, 2004. View at Google Scholar · View at Scopus
  297. R. Masella, R. di Benedetto, R. Varì, C. Filesi, and C. Giovannini, “Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes,” Journal of Nutritional Biochemistry, vol. 16, no. 10, pp. 577–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  298. M. A. Carluccio, M. Massaro, C. Bonfrate et al., “Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the Mediterranean diet,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 2, pp. 220–228, 1999. View at Google Scholar · View at Scopus
  299. M. Massaro, M. A. Carluccio, A. Paolicchi, F. Bosetti, G. Solaini, and R. de Caterina, “Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factorκB through antioxidant effects,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 2-3, pp. 175–181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  300. P. Yaqoob, E. A. Newsholme, and P. C. Calder, “Inhibition of natural killer cell activity by dietary lipids,” Immunology Letters, vol. 41, no. 2-3, pp. 241–247, 1994. View at Publisher · View at Google Scholar · View at Scopus
  301. P. Yaqoob, E. A. Newsholme, and P. C. Calder, “The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation,” Immunology, vol. 82, no. 4, pp. 603–610, 1994. View at Google Scholar · View at Scopus
  302. S. Tsimikas, A. Philis-Tsimikas, S. Alexopoulos, F. Sigari, C. Lee, and P. D. Reaven, “LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 1, pp. 122–130, 1999. View at Google Scholar · View at Scopus
  303. J. Ruano, J. Lopez-Miranda, F. Fuentes et al., “Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients,” Journal of the American College of Cardiology, vol. 46, no. 10, pp. 1864–1868, 2005. View at Publisher · View at Google Scholar · View at Scopus
  304. M. Fitó, R. de La Torre, and M.-I. Covas, “Olive oil and oxidative stress,” Molecular Nutrition and Food Research, vol. 51, no. 10, pp. 1215–1224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  305. G. Lippi, M. Franchini, E. J. Favaloro, and G. Targher, “Moderate red wine consumption and cardiovascular disease risk: beyond the French paradox,” Seminars in Thrombosis and Hemostasis, vol. 36, no. 1, pp. 59–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  306. P. Gresele, C. Cerletti, G. Guglielmini, P. Pignatelli, G. de Gaetano, and F. Violi, “Effects of resveratrol and other wine polyphenols on vascular function: an update,” Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 201–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  307. P. Bališ, A. Púzserová, P. Slezák, N. Sestáková, O. Pecháňová, and I. Bernátová, “Short-term administration of alibernet red wine extract failed to affect blood pressure and to improve endothelial function in young normotensive and spontaneously hypertensive rats,” Physiological Research, vol. 62, no. 6, pp. 631–641, 2013. View at Google Scholar
  308. J. Bornhoeft, D. Castaneda, T. Nemoseck, P. Wang, S. M. Henning, and M. Y. Hong, “The protective effects of green tea polyphenols: lipid profile, inflammation, and antioxidant capacity in rats fed an atherogenic diet and dextran sodium sulfate,” Journal of Medicinal Food, vol. 15, no. 8, pp. 726–732, 2012. View at Publisher · View at Google Scholar
  309. S. V. Nigdikar, N. R. Williams, B. A. Griffin, and A. N. Howard, “Consumption of red wine polyphenols reduces the susceptibility of low- density lipoproteins to oxidation in vivo,” American Journal of Clinical Nutrition, vol. 68, no. 2, pp. 258–265, 1998. View at Google Scholar · View at Scopus
  310. A. Agouni, A.-H. Lagrue-Lak-Hal, H. A. Mostefai et al., “Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa),” PLoS ONE, vol. 4, no. 5, Article ID e5557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  311. G. Scola, D. Conte, P. W. D.-S. Spada et al., “Flavan-3-ol compounds from wine wastes with in vitro and in vivo antioxidant activity,” Nutrients, vol. 2, no. 10, pp. 1048–1059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  312. M. G. Lionetto, M. E. Giordano, A. Calisi, E. Erroi, F. de Nuccio, and T. Schettino, “Effect of the daily ingestion of a purified anthocyanin extract from grape skin on rat serum antioxidant capacity,” Physiological Research, vol. 60, no. 4, pp. 637–645, 2011. View at Google Scholar · View at Scopus
  313. T. Wallerath, G. Deckert, T. Ternes et al., “Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase,” Circulation, vol. 106, no. 13, pp. 1652–1658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  314. K. Karatzi, E. Karatzis, C. Papamichael, J. Lekakis, and A. Zampelas, “Effects of red wine on endothelial function: postprandial studies vs clinical trials,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 10, pp. 744–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  315. J. G. Zou, Z. R. Wang, Y. Z. Huang, K. J. Cao, and J. M. Wu, “Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits,” International Journal of Molecular Medicine, vol. 11, no. 3, pp. 317–320, 2003. View at Google Scholar
  316. R. Jiménez, R. López-Sepúlveda, M. Kadmiri et al., “Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase,” Free Radical Biology and Medicine, vol. 43, no. 3, pp. 462–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  317. A. Cavallaro, T. Ainis, C. Bottari, and V. Fimiani, “Effect of resveratrol on some activities of isolated and in whole blood human neutrophils,” Physiological Research, vol. 52, no. 5, pp. 555–562, 2003. View at Google Scholar · View at Scopus
  318. S. K. Nicholson, G. A. Tucker, and J. M. Brameld, “Effects of dietary polyphenols on gene expression in human vascular endothelial cells,” Proceedings of the Nutrition Society, vol. 67, no. 1, pp. 42–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  319. R. Corder, J. A. Douthwaite, D. M. Lees et al., “Endothelin-1 synthesis red wine,” Nature, vol. 414, no. 6866, pp. 863–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  320. L. F. Rodella, L. Vanella, S. J. Peterson et al., “Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes,” Drug Metabolism Letters, vol. 2, no. 4, pp. 290–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  321. S. Hamed, J. Alshiek, A. Aharon, B. Brenner, and A. Roguin, “Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals,” American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 161–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  322. G. Chiva-Blanch, M. Urpi-Sarda, E. Ros et al., “Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication,” Circulation Research, vol. 111, no. 8, pp. 1065–1068, 2012. View at Publisher · View at Google Scholar
  323. J. H. Stein, J. G. Keevil, D. A. Wiebe, S. Aeschlimann, and J. D. Folts, “Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease,” Circulation, vol. 100, no. 10, pp. 1050–1055, 1999. View at Google Scholar · View at Scopus
  324. A. C. M. Andrade, F. H. Y. Cesena, F. M. Consolim-Colombo et al., “Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects,” Clinics, vol. 64, no. 5, pp. 435–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  325. P.-H. Huang, Y.-H. Chen, H.-Y. Tsai et al., “Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 869–877, 2010. View at Publisher · View at Google Scholar · View at Scopus
  326. C. D. Venkov, P. R. Myers, M. A. Tanner, M. Su, and D. E. Vaughan, “Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression,” Thrombosis and Haemostasis, vol. 81, no. 4, pp. 638–642, 1999. View at Google Scholar · View at Scopus
  327. J. F. Leikert, T. R. Räthel, P. Wohlfart, V. Cheynier, A. M. Vollmar, and V. M. Dirsch, “Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells,” Circulation, vol. 106, no. 13, pp. 1614–1617, 2002. View at Publisher · View at Google Scholar · View at Scopus
  328. A. M. Cuevas, V. Guasch, O. Castillo et al., “A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers,” Lipids, vol. 35, no. 2, pp. 143–148, 2000. View at Google Scholar · View at Scopus
  329. A. A. Quyyumi, “Prognostic value of endothelial function,” American Journal of Cardiology, vol. 91, no. 12, pp. 19H–24H, 2003. View at Publisher · View at Google Scholar · View at Scopus
  330. T. Neunteufl, S. Heher, R. Katzenschlager et al., “Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain,” American Journal of Cardiology, vol. 86, no. 2, pp. 207–210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  331. J. Lefèvre, S.-É. Michaud, P. Haddad et al., “Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide,” FASEB Journal, vol. 21, no. 14, pp. 3845–3852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  332. P. A. Cahill and E. M. Redmond, “Alcohol and cardiovascular disease-modulation of vascular cell function,” Nutrients, vol. 4, no. 4, pp. 297–318, 2012. View at Publisher · View at Google Scholar · View at Scopus
  333. A. P. Whelan, W. H. F. Sutherland, M. P. McCormick, D. J. Yeoman, S. A. de Jong, and M. J. A. Williams, “Effects of white and red wine on endothelial function in subjects with coronary artery disease,” Internal Medicine Journal, vol. 34, no. 5, pp. 224–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  334. S. Agewall, S. Wright, R. N. Doughty, G. A. Whalley, M. Duxbury, and N. Sharpe, “Does a glass of red wine improve endothelial function?” European Heart Journal, vol. 21, no. 1, pp. 74–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  335. M. Hashimoto, S. Kim, M. Eto et al., “Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery,” American Journal of Cardiology, vol. 88, no. 12, pp. 1457–1460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  336. V. B. Schini-Kerth, C. Auger, J.-H. Kim, N. Etienne-Selloum, and T. Chataigneau, “Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF,” Pflügers Archiv, vol. 459, no. 6, pp. 853–862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  337. M. A. B. Rosales, K. C. Silva, J. B. L. de Faria, and J. M. L. de Faria, “Exogenous sod mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats,” Investigative Ophthalmology and Visual Science, vol. 51, no. 8, pp. 4327–4336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  338. C. G. Schnackenberg and C. S. Wilcox, “The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes,” Kidney International, vol. 59, no. 5, pp. 1859–1864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  339. D. S. Weber and K. K. Griendling, “The Yin/Yang of superoxide dismutase mimetics: potential cardiovascular therapies?” British Journal of Pharmacology, vol. 139, no. 6, pp. 1059–1060, 2003. View at Publisher · View at Google Scholar · View at Scopus
  340. J. A. Rodríguez, A. Grau, E. Eguinoa et al., “Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro,” Atherosclerosis, vol. 165, no. 1, pp. 33–40, 2002. View at Publisher · View at Google Scholar · View at Scopus
  341. J.-H. Bae, E. Bassenge, K.-B. Kim et al., “Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress,” Atherosclerosis, vol. 155, no. 2, pp. 517–523, 2001. View at Publisher · View at Google Scholar · View at Scopus
  342. R. Maio, M. Perticone, A. Sciacqua et al., “Oxidative stress impairs endothelial function in nondipper hypertensive patients,” Cardiovascular Therapeutics, vol. 30, no. 2, pp. 85–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  343. L. V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z. S. Katusic, “Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity,” Circulation Research, vol. 92, no. 1, pp. 88–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  344. A. R. Crecelius, B. S. Kirby, W. F. Voyles, and F. A. Dinenno, “Nitric oxide, but not vasodilating prostaglandins, contributes to the improvement of exercise hyperemia via ascorbic acid in healthy older adults,” American Journal of Physiology, vol. 299, no. 5, pp. H1633–H1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  345. J. D. Krier, E. L. Ritman, Z. Bajzer, J. C. Romero, A. Lerman, and L. O. Lerman, “Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function,” American Journal of Physiology, vol. 281, no. 4, pp. F630–F638, 2001. View at Google Scholar · View at Scopus
  346. J. Neužil, S. R. Thomas, and R. Stocker, “Requirement for, promotion, or inhibition by α-tocopherol of radical- induced initiation of plasma lipoprotein lipid peroxidation,” Free Radical Biology and Medicine, vol. 22, no. 1-2, pp. 57–71, 1996. View at Publisher · View at Google Scholar · View at Scopus
  347. J. F. Keaney Jr., J. M. Gaziano, A. Xu et al., “Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits,” Journal of Clinical Investigation, vol. 93, no. 2, pp. 844–851, 1994. View at Google Scholar · View at Scopus
  348. D. Versari, E. Daghini, M. Rodriguez-Porcel et al., “Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs,” Hypertension, vol. 47, no. 3, pp. 475–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  349. E. Daghini, X.-Y. Zhu, D. Versari et al., “Antioxidant vitamins induce angiogenesis in the normal pig kidney,” American Journal of Physiology, vol. 293, no. 1, pp. F371–F381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  350. S. R. J. Maxwell, “Coronary artery disease—free radical damage, antioxidant protection and the role of homocysteine,” Basic Research in Cardiology, vol. 95, supplement 1, pp. I65–I71, 2000. View at Google Scholar · View at Scopus
  351. R. J. Reiter, D.-X. Tan, S. D. Paredes, and L. Fuentes-Broto, “Beneficial effects of melatonin in cardiovascular disease,” Annals of Medicine, vol. 42, no. 4, pp. 279–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  352. R. Hardeland, D.-X. Tan, and R. J. Reiter, “Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines,” Journal of Pineal Research, vol. 47, no. 2, pp. 109–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  353. G. Paradies, G. Petrosillo, V. Paradies, R. J. Reiter, and F. M. Ruggiero, “Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease,” Journal of Pineal Research, vol. 48, no. 4, pp. 297–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  354. R. J. Reiter, D.-X. Tan, and A. Korkmaz, “The circadian melatonin rhythm and its modulation: possible impact on hypertension,” Journal of Hypertension, vol. 27, supplement 6, pp. S17–S20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  355. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, J. J. Sanchez-Sanchez, J. C. Kaski, and R. J. Reiter, “Melatonin and circadian biology in human cardiovascular disease,” Journal of Pineal Research, vol. 49, no. 1, pp. 14–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  356. L. Paulis, O. Pechanova, J. Zicha et al., “Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment,” Journal of Hypertension, vol. 28, supplement 1, pp. S19–S24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  357. F. Simko and L. Paulis, “Melatonin as a potential antihypertensive treatment,” Journal of Pineal Research, vol. 42, no. 4, pp. 319–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  358. C. F. Reyes-Toso, L. M. Linares, C. R. Ricci et al., “Melatonin restores endothelium-dependent relaxation in aortic rings of pancreatectomized rats,” Journal of Pineal Research, vol. 39, no. 4, pp. 386–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  359. C. F. Reyes-Toso, D. Obaya-Naredo, C. R. Ricci et al., “Effect of melatonin on vascular responses in aortic rings of aging rats,” Experimental Gerontology, vol. 42, no. 4, pp. 337–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  360. M. M. Anwar, A.-R. M. A. Meki, and H. H. Abu Rahma, “Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators,” Comparative Biochemistry and Physiology C, vol. 130, no. 3, pp. 357–367, 2001. View at Publisher · View at Google Scholar · View at Scopus
  361. M. L. Pita, M. Hoyos, I. Martin-Lacave, C. Osuna, J. M. Fernández-Santos, and J. M. Guerrero, “Long-term melatonin administration increases polyunsaturated fatty acid percentage in plasma lipids of hypercholesterolemic rats,” Journal of Pineal Research, vol. 32, no. 3, pp. 179–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  362. S. Tengattini, R. J. Reiter, D.-X. Tan, M. P. Terron, L. F. Rodella, and R. Rezzani, “Cardiovascular diseases: protective effects of melatonin,” Journal of Pineal Research, vol. 44, no. 1, pp. 16–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  363. H. Girouard and J. de Champlain, “Inhibitory effect of melatonin on α1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats,” American Journal of Hypertension, vol. 17, no. 4, pp. 339–346, 2004. View at Publisher · View at Google Scholar · View at Scopus